This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Catalan Institute of Nanoscience and Nanotechnology | |
|---|---|
| Name | Catalan Institute of Nanoscience and Nanotechnology |
| Native name | Institut Català de Nanociència i Nanotecnologia |
| Established | 2003 |
| Location | Barcelona, Catalonia, Spain |
| Director | Josep Samitier |
| Type | Research institute |
| Affiliations | CSIC, ICREA, Universitat Autònoma de Barcelona |
Catalan Institute of Nanoscience and Nanotechnology is a research institute located in Barcelona, Catalonia, Spain, focused on nanoscale science and technology. It operates within a network of European and global institutions and participates in projects bridging materials science, biomedicine, and information technology. The institute collaborates with universities, research councils, and industry partners to translate nanoscale discoveries into applications.
The institute was founded in 2003 with participation from the Spanish National Research Council, the Government of Catalonia, and the Autonomous University of Barcelona, and it emerged during a period of expansion of nanoscience centers including the Max Planck Society, the CNRS, the CERN, and the European Molecular Biology Laboratory. Early leadership connected the institute to figures associated with Bell Labs, IBM Research, and the Wellcome Trust, while strategic partnerships linked it to the European Commission framework programmes and the Horizon 2020 initiative. Over time, the institute established relations with the Massachusetts Institute of Technology, the California Institute of Technology, the University of Cambridge, the University of Oxford, the ETH Zurich, the Weizmann Institute of Science, and the Korea Advanced Institute of Science and Technology, fostering exchanges with groups from the National Institute of Standards and Technology, the Riken, and the Oak Ridge National Laboratory. Major expansions paralleled developments at the Barcelona Supercomputing Center, the Institut de Recerca Biomèdica de Barcelona, and the Hospital Clínic de Barcelona.
The institute's mission aligns with priorities set by the European Research Council, the European Institute of Innovation and Technology, and the United Nations Educational, Scientific and Cultural Organization to develop nanotechnology for health, energy, and information. Research programs cover quantum materials linked to the Nobel Prize laureates' domains, nanoscale devices related to Graphene discoveries, biomaterials influenced by work at the Max Planck Institute for Biophysical Chemistry, and nanophotonics with ties to laboratories at the Institute of Photonic Sciences and the Fraunhofer Society. Projects often intersect with translational agendas promoted by the Bill & Melinda Gates Foundation, the Wellcome Trust, and the Human Frontier Science Program.
Governance includes a board with members from the Catalan Ministry of Business and Knowledge, the Spanish Ministry of Science, and representatives from universities such as the University of Barcelona and the Pompeu Fabra University. Scientific advisory committees have included researchers associated with the Royal Society, the European Academy of Sciences, the American Physical Society, and the Institute of Electrical and Electronics Engineers. The institute employs principal investigators with profiles similar to groups at the National Institutes of Health, the Howard Hughes Medical Institute, and the European Molecular Biology Organization, and administrative collaboration occurs with agencies like the Barcelona City Council and agencies affiliated with the European Commission.
Laboratory infrastructure includes cleanrooms comparable to facilities at the Paul Scherrer Institute, advanced microscopy suites paralleling capabilities at the Max Planck Institute for Intelligent Systems, and nanofabrication tools akin to those at the Advanced Micro Foundry and the Nanolithography Center. Shared equipment strategies echo models used by the Large Hadron Collider collaborations and the European XFEL, while high-performance computing partnerships mirror links with the Barcelona Supercomputing Center and the Argonne National Laboratory. Clinical and translational facilities enable collaboration with hospitals such as the Vall d'Hebron University Hospital and research institutes like the Catalan Institute of Oncology.
The institute has participated in European consortia coordinated alongside institutions such as Imperial College London, École Normale Supérieure, Politecnico di Milano, Technische Universität München, University of Milan, Technical University of Denmark, Chalmers University of Technology, and Delft University of Technology. Collaborative projects have interfaced with industry partners including Siemens, Philips, Novartis, Roche, BASF, and GlaxoSmithKline, and technology transfer activities resemble models used by Cambridge Enterprise and Oxford University Innovation. International research networks include ties to the International Iberian Nanotechnology Laboratory, the Kavli Foundation, the Gordon and Betty Moore Foundation, and the European Nanotechnology Community, and project funding has come from sources like the Marie Skłodowska-Curie Actions, the ERC Starting Grants, and national programs from the Ministry of Economy of Spain.
Training programs integrate with degree programs at the Autonomous University of Barcelona, the University of Barcelona, and the Universitat Politècnica de Catalunya, and doctoral supervision aligns with frameworks established by the European University Association and the Erasmus Mundus programme. The institute hosts seminars featuring speakers from the Royal Institution, the American Chemical Society, the Materials Research Society, and the Optical Society of America, and runs outreach resembling initiatives by the Science Museum, London, the Cité des Sciences et de l'Industrie, and the Smithsonian Institution to promote public engagement in nanoscience.
Researchers have achieved recognition akin to awards from the Royal Society, the European Research Council, the International Union of Pure and Applied Chemistry, and national prizes such as the Prince of Asturias Awards. Technology transfers have led to spin-offs comparable to companies incubated through Cambridge Innovation Capital and partnerships with accelerators like Seedcamp and Y Combinator model programs. Societal impact includes contributions to biomedical devices used in clinical settings such as the Hospital de la Santa Creu i Sant Pau and advancements in renewable energy technologies influenced by collaborations with Iberdrola and Siemens Gamesa Renewable Energy.
Category:Nanotechnology research centers in Spain